You have 9 free searches left this month | for more free features.

c-Met inhibitor

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Colorectal Cancer Trial (LB-100, Azenosertib)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • (no location specified)
Oct 31, 2023

Refractory Soft Tissue Sarcomas Trial run by the NCI (Cabozantinib)

Active, not recruiting
  • Refractory Soft Tissue Sarcomas
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 5, 2022

Advanced Hepatocellular Carcinoma With c-MET Dysregulation Trial in Worldwide (INC280)

Active, not recruiting
  • Advanced Hepatocellular Carcinoma With c-MET Dysregulation
  • Nanjing, Jiangsu, China
  • +7 more
Jan 12, 2023

Neuromyelitis Optica Spectrum Disorder, NMOSD, AQP4+ NMOSD Trial

Not yet recruiting
  • Neuromyelitis Optica Spectrum Disorder
  • +2 more
    • (no location specified)
    Jul 21, 2023

    Advanced Solid Tumor, NSCLCs Trial in Houston (Adagrasib, Olaparib)

    Not yet recruiting
    • Advanced Solid Tumor
    • Non-small Cell Lung Cancers
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 15, 2023

    Digestive Cancer Trial (RC108)

    Not yet recruiting
    • Digestive Cancer
    • (no location specified)
    Nov 17, 2022

    Locally Advanced Colon Cancer Trial (Serplulimab, short-term radiotherapy, Oxaliplatin)

    Not yet recruiting
    • Locally Advanced Colon Cancer
    • (no location specified)
    Feb 16, 2023

    NSCLC Trial in Worldwide (INC280, Gefitinib)

    Completed
    • Non-small Cell Lung Cancer
    • Woolloongabba, Queensland, Australia
    • +30 more
    Mar 12, 2021

    NSCLC Trial in Guangzhou (PLB1001)

    Completed
    • Non-Small Cell Lung Cancer
    • Guangzhou, Guangdong, China
      Guangdong General Hospital
    Nov 20, 2019

    Metastatic Breast Cancer, Breast Cancer Trial in Houston (Neratinib, Capmatinib)

    Not yet recruiting
    • Metastatic Breast Cancer
    • Breast Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 16, 2022

    Solid Tumor Trial in Worldwide (BYON3521)

    Recruiting
    • Solid Tumor
    • Brussels, Belgium
    • +3 more
    Aug 2, 2022

    Posterior Brain Fossa Tumors in Children Trial in Bron (11C-MET PET/MRI)

    Completed
    • Posterior Brain Fossa Tumors in Children
    • 11C-MET PET/MRI
    • Bron, France
      Hospices Civils de Lyon - Groupement Hospitalier Est - Hôpital F
    Nov 29, 2021

    Acute Myeloid Leukemia (AML) Trial in Birmingham, San Francisco, New York (ZN-d5 ZN-c3, ZN-c3)

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • Birmingham, Alabama
    • +2 more
    Jan 3, 2023

    Healthy Adults Trial in Dallas (Treatment A, Treatment B)

    Not yet recruiting
    • Healthy Adults
    • Treatment A
    • Treatment B
    • Dallas, Texas
      Labcorp Clinical Research Unit Inc
    May 11, 2023

    Relapsed or Refractory Lymphoma Trial in Miami (Itraconazole 200 mg, Fluconazole 400 mg, Rifampin 600 mg)

    Completed
    • Relapsed or Refractory Lymphoma
    • Itraconazole 200 mg
    • +3 more
    • Miami, Florida
      QPS- Miami
    Jan 12, 2023

    Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial (PHA-022121 low dose, PHA-022121 medium

    Recruiting
    • Hereditary Angioedema
    • +11 more
    • PHA-022121 low dose
    • +3 more
    • Birmingham, Alabama
    • +7 more
    Dec 5, 2022

    Advanced Gastric Adenocarcinoma Trial in Seoul (Volitinib)

    Completed
    • Advanced Gastric Adenocarcinoma
    • Seoul, Korea, Republic of
      Samsung Medical center
    Jun 13, 2022

    Sarcoma, Stomach Tumors, Tumors Trial run by the NCI (Pazopanib, ARQ 197)

    Completed
    • Sarcoma
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jun 23, 2021

    Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Boston (Zentalis, Gemzar)

    Not yet recruiting
    • Advanced Pancreatic Adenocarcinoma
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Aug 23, 2023

    c-MET Expression and EGFR Gene Mutation Correlation With

    Completed
    • Non-small Cell Lung Cancer Metastatic
    • Non-small Cell Lung Cancer Recurrent
      • Hwasun, Korea, Republic of
        Chonnam National University Hwasun Hospital
      Aug 1, 2021

      Solid Tumor, Adult, Metastatic Solid Tumor, Metastatic NSCLC Trial in Adelaide (BBP-398, sotorasib)

      Recruiting
      • Solid Tumor, Adult
      • +3 more
      • Adelaide, South Australia, Australia
        Cancer Research SA
      Aug 15, 2022

      Metastatic Pancreatic Cancer Trial in Houston (MRTX849)

      Not yet recruiting
      • Metastatic Pancreatic Cancer
      • Houston, Texas
        M D Anderson Cancer Center
      Nov 22, 2022

      Migraine, Episodic Migraine, Headache Trial in New York (Click Digital Therapeutic)

      Recruiting
      • Migraine
      • +3 more
      • Click Digital Therapeutic
      • New York, New York
        Click Therapeutics
      Aug 15, 2023

      Teenagers and Non-histaminergic Angioedema With Normal C1

      Not yet recruiting
      • Hereditary Angioedema (HAE)
      • Angioedema
      • No Intervention
      • (no location specified)
      Jan 5, 2023

      MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma Trial in Columbus (drug, biological,

      Active, not recruiting
      • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
      • +9 more
      • BTK inhibitor PCI-32765
      • +5 more
      • Columbus, Ohio
        Ohio State University Medical Center
      Jun 27, 2022